Moreover, following RRM2 knockdown, we observed a notable increase in the rates of necroptosis and apoptosis in prostate cancer cells, as depicted in Fig. 4I-L and Additional file 1: Figure S1A–D. Here, RRM2 is linked to prostate carcinoma.